MedPath

Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic

Completed
Conditions
Alcoholic Neuropathy
Liver Failure
DEPRESSIVE DISORDER
HEART DISEASE
Interventions
Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment
Registration Number
NCT01081197
Lead Sponsor
Helse Nord-Trøndelag HF
Brief Summary

Alcohol abuse is associated with a variety of clinical diseases, but studies on prevalence of different somatic diseases among alcohol abusers are lacking. Studies on populations in an out-day patients' clinic are also lacking.

The investigators aim to study somatic health standard in an out-day patients' clinic population of alcohol abusers, with regard to prevalence of different kinds of somatic diseases, and how the interaction of somatic and psychiatric treatment can influence on patients quality of life. Clinical examination including blood samples and echocardiographic examinations in all participants, other additional examinations (as x-ray, CT or MRI if indicated by clinical findings).

Detailed Description

Retrospective methods will be used to study former somatic disease, cross-section design to study present somatic disease and prospective design to study quality of life, psychiatric and somatic health after combination of psychiatric and somatic examinations and treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Alcohol abusers reffered to the out-day patients' clinic at Dep. of Psychiatry, Levanger Hospital, Norway
Exclusion Criteria
  • Not consenting to participate
  • Not able to consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Out-day patients' clinicPsychiatric and somatic examinations and ,if clinical indicated, treatmentAlcohol abusers referred to out-day patients' clinic which consent to participate in the study
Primary Outcome Measures
NameTimeMethod
Prevalence of different kinds of somatic disease3 months after inclusion

Prevalence of somatic disease at study attendance of any kind, specified for heart disease, gall- and liver disease, neuropathic disease.

Secondary Outcome Measures
NameTimeMethod
Prevalence of former somatic disease3 months after inclusion

Prevalence of former somatic disease investigated by anamnestic examination, search in patient journals and communication with the patients community health service.

Outcome of psychiatric and somatic treatment of alcohol abusers1 year after stopped inclusion

Quality of life and score of somatic and psychiatric health 1 year after inclusion

Trial Locations

Locations (1)

Levanger Hospital, Dep. of Psychiatry

🇳🇴

Levanger, Norway

© Copyright 2025. All Rights Reserved by MedPath